FDA Adverse Event Injury Summary report: N

REVITIVE DX

MDR report key: 7556818 · Received May 31, 2018

Report

Report Number
3010078417-2018-00008
Event Type
Injury
Date Received
May 31, 2018
Date of Event
March 6, 2017
Report Date
May 31, 2018
Manufacturer
ACTEGY LTD
Product Code
NUH
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

PATIENT OUTCOME: PATIENT TREATED WITH STENT IMPLANT, RECOVERING AT HOME FOLLOWING HOSPITAL DISCHARGE 5 DAYS AFTER THE INCIDENT. PATIENT CORRECTIVE ACTION: PATIENT HAS DISCONTINUED USE OF THE DEVICE. MANUFACTURER'S PRELIMINARY ANALYSIS: DEVICE HAS BEEN RETURNED FOR TESTING AND WAS FOUND TO BE OPERATING WITHIN INTENDED SPECIFICATION. INITIAL CORRECTIVE ACTION: DEVICE RETURNED FOR INVESTIGATION. FURTHER INFORMATION REQUESTED TO ENABLE THOROUGH INVESTIGATION AND MEDICAL OPINION TO BE SOUGHT.

Description of Event or Problem · 1

CUSTOMER PURCHASED THE DEVICE (B)(6) 2017 FOR DIABETIC NEUROPATHY. USED THE DEVICE FOR THE 2ND TIME ON (B)(6) 2017, SETTINGS UNKNOWN. ON THE MORNING OF (B)(6) 2017, JR SUFFERED A HEART ATTACK AND WAS HOSPITALISED. TREATMENT INCLUDED STENT IMPLANT, SPECIFIC LOCATION OF STENT UNKNOWN. (B)(6) DISCHARGED FROM HOSPITAL (B)(6) 2017. RECOVERING WELL AT HOME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
401584 REVITIVE DX CIRCULATION BOOSTER NUH ACTEGY LTD REVITIVE DX

Patients

Seq Age Sex Outcome Treatment
1 0 YR Hospitalization